Job Description:The SMid/ Large Cap Biotechnology Equity Research team covers companies spanning three main disease areas of oncology, central nervous system disorders, and rare diseases. The lead analyst is top three ranked in the Institutional Investor vote for the smid biotech category. In 2021 the team worked on several priced IPOs and add ons and is currently vetting several additional transactions. The candidate for this position should be intellectually curious and have a deep desire ...
Insert additional messaging here.
